Literature DB >> 4006239

Vascular hypertrophy in borderline hypertension: relationship to blood pressure and sympathetic drive.

B Egan, S Julius.   

Abstract

While borderline hypertension increases the chance for cardiovascular disease, most with borderline hypertension will not experience problems. Thus, the risk of intervening probably outweighs benefit for the majority. However, those with target organ damage are probably at higher risk and might benefit from more aggressive management. Therefore, we assessed vascular hypertrophy and average home blood pressures in patients with borderline hypertension which might be of value in therapeutic planning. Minimum forearm vascular resistance (mFAVR) was used as an index of vascular hypertrophy. Comparing ten normotensive controls to twenty individuals with borderline hypertension revealed a significant difference in mFAVR (1.7 +/- 0.06 vs 2.1 +/- 0.1, p less than .05). There were obvious differences in blood pressure between normotensives and borderlines which contributed to differences in mFAVR. However, within the group with borderline hypertension, no relationship was apparent between mean blood pressure and mFAVR, r = 0.13, NS. Among the borderline hypertensives, baseline plasma norepinephrine correlated with mFAVR, r = 0.48, p less than .05, suggesting that the sympathetic nervous system contributes to vascular hypertrophy in this group. In a separate group of individuals with nine normotensives and nine borderline hypertensives we wished to find if average home blood pressure would correlate better with mFAVR than a single laboratory measurement. While both the home (r = 0.56, p less than .05) and laboratory (r = 0.66, p less than .01) MBP correlated significantly with mFAVR, the data did not confirm the hypothesis that the average home blood pressures would better predict the degree of vascular hypertrophy. These data show that a substantial proportion of patients with borderline hypertension have evidence for vascular hypertrophy, sympathetic drive might contribute to vascular hypertrophy in borderline hypertension, average home blood pressures did not aid in separating those with and without evidence for vascular hypertrophy.

Entities:  

Mesh:

Year:  1985        PMID: 4006239     DOI: 10.3109/10641968509073544

Source DB:  PubMed          Journal:  Clin Exp Hypertens A        ISSN: 0730-0077


  6 in total

Review 1.  Prehypertension: a possible target for antihypertensive medication.

Authors:  S D Nesbitt; S Julius
Journal:  Curr Hypertens Rep       Date:  2000-08       Impact factor: 5.369

Review 2.  Selective alpha 1-adrenoreceptor blockers in the treatment of hypertension: should we be using them more?

Authors:  M Ligueros; R Unwin; M Wilkins
Journal:  Clin Auton Res       Date:  1991-09       Impact factor: 4.435

3.  Hemodynamics and Vascular Hypertrophy in African Americans and Caucasians With High Blood Pressure.

Authors:  LaBarron K Hill; Andrew Sherwood; James A Blumenthal; Alan L Hinderliter
Journal:  Am J Hypertens       Date:  2016-12-01       Impact factor: 2.689

4.  Psychological and physiological predictors of lipids in black males.

Authors:  E H Johnson; P Collier; P Nazzaro; D C Gilbert
Journal:  J Behav Med       Date:  1992-06

Review 5.  Abnormalities of autonomic nervous control in human hypertension.

Authors:  S Julius
Journal:  Cardiovasc Drugs Ther       Date:  1994-03       Impact factor: 3.727

6.  Alterations in vasomotor systems and mechanics of resistance-sized mesenteric arteries from SHR and WKY male rats following in vivo testosterone manipulation.

Authors:  Jonathan D Toot; John J Reho; Rolando J Ramirez; Jacqueline Novak; Daniel L Ely
Journal:  Biol Sex Differ       Date:  2012-01-03       Impact factor: 5.027

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.